Basic Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 100723
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.100723
Figure 5
Figure 5 After Octamer transcription factor 4 expression changes, the sensitivity of pancreatic cancer BxPC3 cells to gemcitabine changes. A and B: Effects of different gemcitabine concentrations on the proliferative ability of BxPC-3 cells; C: Effects of changes in OCT4 expression on the proliferative ability of BxPC-3 cells. aP < 0.05. OCT4: Octamer transcription factor 4.